VENBETA6890
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VENBETA6890, covering 2025-07-22 to 2025-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgA [Phase 1]